RT Journal
A1 Voelker R
T1 AS trials advance for a malaria vaccine, policy makers urged to plan for its use
JF JAMA
JO JAMA
YR 2010
FD December 1
VO 304
IS 21
SP 2348
OP 2348
DO 10.1001/jama.304.21.2348
UL http://dx.doi.org/10.1001/jama.304.21.2348
AB 
“After decades of research and tens of millions of dollars invested  . . .  it would be scandalous if this vaccine just sits on the shelf,” said Yvette Collymore, MA, of the nonprofit PATH Malaria Vaccine Initiative (MVI), during a recent Washington, DC, conference.